Back
NAPCO Security Technologies Vs. Kymera Therapeutics Industry Stock Comparison
Sell
28
NSSC
NAPCO Security Technologies
Last Price:
36.49
Seasonality Move:
1.92%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
44.66
Seasonality Move:
25.63%
Sell
28
NAPCO Security Technologies (NSSC)
is a Sell
Is NAPCO Security Technologies a Buy, Sell or Hold?
- The current NAPCO Security Technologies [NSSC] share price is $36.57. The Score for NSSC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- NSSC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.88. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NSSC Stock Price Chart
What is NAPCO Security Technologies's stock price today?
-
The NAPCO Security Technologies share price today is $36.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NSSC is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.88
The current trend is moderately bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NSSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.64 | Sell |
| Relative Strength Index (14 RSI): | 29.79 | Sell |
| Chaikin Money Flow: | 512730 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.5 - 56.1) | Sell |
| Bollinger Bands (100): | (43.98 - 54.9) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.1 | Buy |
| Relative Strength Index (14 RSI): | 55.23 | Buy |
| Chaikin Money Flow: | 209294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.77 - 48.09) | Buy |
| Bollinger Bands (100): | (32.74 - 44.46) | Buy |
NSSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.75 | Sell |
| 20-day SMA: | 47.94 | Sell |
| 50-day SMA: | 51.53 | Sell |
| 200-day SMA: | 43.49 | Sell |
| 8-day EMA: | 39.47 | Sell |
| 20-day EMA: | 45.05 | Sell |
| 50-day EMA: | 48.81 | Sell |
| 200-day EMA: | 44.21 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.77 | Buy |
| 20-day SMA: | 46.4 | Buy |
| 50-day SMA: | 42.99 | Buy |
| 200-day SMA: | 35.58 | Buy |
| 8-day EMA: | 46.64 | Buy |
| 20-day EMA: | 46.04 | Buy |
| 50-day EMA: | 43.26 | Buy |
| 200-day EMA: | 36.12 | Buy |
NAPCO Security Technologies Earnings Growth & NSSC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.03 per share, an increase this year of $0.60 per share, and an increase next year of $0.19 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
NAPCO Security Technologies Technical Analysis
| Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||